Finnish veterinary clinics are leading the way in adopting DeepScan's revolutionary Cell-Free DNA (CFD) testing technology, which enables early detection of cancer in dogs before symptoms become apparent.
## The Technology Behind DeepScan
DeepScan's CFD test analyzes fragments of DNA released by damaged or dying cells in a dog's bloodstream. When cancer or other diseases are present, cell death increases, leading to elevated levels of cell-free DNA that can be detected through this non-invasive blood test.
## Impact on Finnish Veterinary Practice
Dr. Emma Virtanen, a leading veterinarian in Helsinki, explains: "The CFD test has transformed how we approach canine health screening. We can now detect potential issues months before traditional diagnostic methods would identify them."
## Early Results Show Promise
Initial studies in Finnish clinics have shown remarkable results:
- 89% accuracy in detecting various cancer types
- Detection possible 6-12 months before clinical symptoms
- Reduced need for invasive diagnostic procedures
## Future of Veterinary Medicine
As more Finnish clinics adopt this technology, DeepScan is positioning Finland as a leader in veterinary innovation. The company plans to expand its services across Europe in the coming months.
"This is just the beginning," says Dr. Virtanen. "We're seeing the future of preventive veterinary medicine, and it's incredibly exciting."